BioCentury
ARTICLE | Clinical News

Becocalcidiol: Phase IIb data

June 20, 2005 7:00 AM UTC

In a double-blind, vehicle-controlled, U.S. Phase IIb in 185 patients showed that both the high- and low-dose becocalcidiol met the primary endpoint compared with vehicle. More than 5 times the number...